These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16917950)

  • 1. Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD.
    Mick E; Biederman J; Spencer T; Faraone SV; Sklar P
    Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):890-4. PubMed ID: 16917950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.
    Contini V; Victor MM; Marques FZ; Bertuzzi GP; Salgado CA; Silva KL; Sousa NO; Grevet EH; Belmonte-de-Abreu P; Bau CH
    J Neural Transm (Vienna); 2010 Feb; 117(2):269-76. PubMed ID: 20049490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T; Rohde LA; Hutz MH
    Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.
    Kambeitz J; Romanos M; Ettinger U
    Pharmacogenomics J; 2014 Feb; 14(1):77-84. PubMed ID: 23588108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
    Kooij JS; Boonstra AM; Vermeulen SH; Heister AG; Burger H; Buitelaar JK; Franke B
    Am J Med Genet B Neuropsychiatr Genet; 2008 Mar; 147B(2):201-8. PubMed ID: 17955457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.
    Gruber R; Joober R; Grizenko N; Leventhal BL; Cook EH; Stein MA
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):233-9. PubMed ID: 19519258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
    Contini V; Rovaris DL; Victor MM; Grevet EH; Rohde LA; Bau CH
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):555-60. PubMed ID: 22709890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.
    Kereszturi E; Tarnok Z; Bognar E; Lakatos K; Farkas L; Gadoros J; Sasvari-Szekely M; Nemoda Z
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1431-5. PubMed ID: 18214865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic imaging study with [Tc-
    Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
    Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
    Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.
    Tharoor H; Lobos EA; Todd RD; Reiersen AM
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jun; 147B(4):527-30. PubMed ID: 17948872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder.
    Agudelo JA; Gálvez JM; Fonseca DJ; Mateus HE; Talero-Gutiérrez C; Velez-Van-Meerbeke A
    Neurologia; 2015 Apr; 30(3):137-43. PubMed ID: 24461309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the DAT1 gene and the effects of methylphenidate administration in adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
    Inci Kenar AN; Ünal GA; Güler H; Albuz B; Kıroğlu Y; Erdal ME; Herken H
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1373-8. PubMed ID: 27097961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.
    Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ
    Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density.
    VanNess SH; Owens MJ; Kilts CD
    BMC Genet; 2005 Nov; 6():55. PubMed ID: 16309561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.
    Barr CL; Xu C; Kroft J; Feng Y; Wigg K; Zai G; Tannock R; Schachar R; Malone M; Roberts W; Nöthen MM; Grünhage F; Vandenbergh DJ; Uhl G; Sunohara G; King N; Kennedy JL
    Biol Psychiatry; 2001 Feb; 49(4):333-9. PubMed ID: 11239904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.
    Polanczyk G; Zeni C; Genro JP; Roman T; Hutz MH; Rohde LA
    Pharmacogenomics; 2005 Apr; 6(3):225-34. PubMed ID: 16013954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association studies of dopamine D4 receptor gene and dopamine transporter gene polymorphisms in Han Chinese patients with attention deficit hyperactivity disorder].
    Qian Q; Wang Y; Li J; Yang L; Wang B; Zhou R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):412-8. PubMed ID: 12947560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.
    de Azeredo LA; Rovaris DL; Mota NR; Polina ER; Marques FZ; Contini V; Vitola ES; Belmonte-de-Abreu P; Rohde LA; Grevet EH; Bau CH
    Eur Arch Psychiatry Clin Neurosci; 2014 Aug; 264(5):401-8. PubMed ID: 24487615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.